• Female participants aged between 18 and 80 years
• At increased risk for ovarian cancer defined by at least one first-degree relative with ovarian, primary peritoneal, or fallopian tube cancer
• At increased risk defined by at least two first or second-degree relatives diagnosed before age 50 with ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer with hereditary cancer syndrome (e.g., BRCA1/2 or Lynch Syndrome) or increased risk as deemed by a certified genetic counselor
• Personal or family history of hereditary cancer syndrome increasing gynecologic cancer risk
• Undergoing surgery for a gynecologic condition including diagnosis of reproductive cancer, benign gynecological condition, highly suspicious adnexal mass, or risk-reducing prophylactic oophorectomy

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety